Get Intuniv Online

Intuniv is an extended-release form of guanfacine, a non-stimulant medication that works by activating alpha-2A adrenergic receptors in the prefrontal cortex. This helps improve attention regulation, impulse control, and behavioral symptoms associated with ADHD.

No. Intuniv (guanfacine ER) is not a stimulant and is not a DEA scheduled controlled substance. This makes it an option for patients who prefer or require a non-stimulant approach to ADHD treatment.

Common side effects include sleepiness, headache, fatigue, dizziness, and decreased blood pressure or heart rate. These effects are often dose-dependent and may improve with gradual dose titration. Your physician will discuss monitoring recommendations.

Clinical improvement with Intuniv is generally gradual. Some patients notice early changes within 1 to 2 weeks, but full therapeutic benefit typically develops over several weeks as the dose is adjusted to the optimal level.

Intuniv is sometimes used alongside other ADHD treatments under physician supervision. It is important to disclose all current medications to your Doctronic physician, as guanfacine can interact with certain antihypertensives, CNS depressants, and other drugs.

A prior clinical diagnosis of ADHD from a qualified healthcare provider is required for Doctronic to prescribe Intuniv. Our physicians will review your diagnostic history as part of the evaluation process and may request supporting information.

Doctronic uses an AI-powered evaluation to gather your symptom history and medical background, which is then reviewed by a licensed physician. If appropriate, the physician creates a personalized treatment plan that may include a prescription sent to your preferred pharmacy.

Yes. Doctronic's platform is staffed by licensed physicians, is HIPAA-compliant, and follows the same standard-of-care requirements as an in-person visit. All prescribing decisions are made and audited by qualified medical professionals.